Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease - Wikidata - wikimedia - TriplyDB

Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease

Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease

http://www.wikidata.org/entity/Q37151436

about

Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.Insulin resistance impairs nigrostriatal dopamine function Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats Effects of discontinuing a high-fat diet on mitochondrial proteins and 6-hydroxydopamine-induced dopamine depletion in rats.Role of vitamin d in Parkinson's disease.Moieties in antidiabetic drugs as a target of insulin receptors in association with common neurological disorders.A high fat diet alters metabolic and bioenergetic function in the brain: A magnetic resonance spectroscopy study.Targeting metabolic inflammation in Parkinson's disease: implications for prospective therapeutic strategies.Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection.Brain areas and pathways in the regulation of glucose metabolism.Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases.Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells.Age-related changes in HSP25 expression in basal ganglia and cortex of F344/BN rats.The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia.Mitochondrial Chaperones in the Brain: Safeguarding Brain Health and Metabolism?

P2860

Q24562763-127604FD-E6C1-46BF-B1E7-DE4FE905A518 Q28067465-48D73FAD-7A41-48EA-A05F-6F125F87A242 Q28081671-44642B3E-BB07-4C1D-8F48-48802C987603 Q34212422-7A421A77-1390-48E6-A67D-F109E49187DC Q35202338-C99183CB-6F5C-4197-A32D-284722E58245 Q35435092-D4A7CE16-5E6B-4CD8-90E9-C233C0937214 Q35688894-F482D2A5-D9D3-4E8E-96A7-917573B5D536 Q35949729-60E1DE17-BD6B-4ECB-B4DD-AFAC04057D98 Q36742174-F6AE1FE0-0B82-4E30-BC5D-C2DAED536092 Q36989464-017A342B-7C40-4A1F-92DA-659FB39E9A16 Q37962621-A1F428A1-0D5D-4B08-9B54-638D3E421022 Q38039489-FA9824E1-761E-4B8C-835D-7480E40A102B Q38126466-156BAFD1-46A4-4E23-BDF2-06638775A9AB Q38197368-7F852336-1425-4CD7-99C0-695E68935EA8 Q39388001-72A57988-38C9-4C88-97EC-C0A0B6CE871D Q39829482-9571EC4E-8801-421B-8B45-AF5756383773 Q50420457-9FBBF2CD-8491-4E21-BE45-17DB78A322D2 Q55283805-2C3B5161-6504-43A6-8A3C-4C07C7EA414B

P2860

Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease

http://www.wikidata.org/entity/Q37151436

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Measures of striatal insulin r ...... e model of Parkinson's disease

@en

Measures of striatal insulin r ...... model of Parkinson's disease.

@nl

type

label

Measures of striatal insulin r ...... e model of Parkinson's disease

@en

Measures of striatal insulin r ...... model of Parkinson's disease.

@nl

prefLabel

Measures of striatal insulin r ...... e model of Parkinson's disease

@en

Measures of striatal insulin r ...... model of Parkinson's disease.

@nl

P1433

Q37151436-86ACCF1B-E7FC-4DC5-8CB6-81A68B562FB2

P1476

Q37151436-82982458-C5B7-4ADE-AEEA-B087C9980993

P2093

Q37151436-34334C2E-A50D-4509-8296-7ABA193E5C28

Q37151436-6100C330-88B4-428B-8F52-9ACBE8B63DEA

Q37151436-9B2CF9AC-4444-40B5-A42A-B31F5095771C

Q37151436-B1E8A2A9-B462-4680-BA6C-2A91D9399AA0

Q37151436-BB170B23-C2F2-4033-8B78-99649B39BDA3

Q37151436-C9E8200C-37E3-40C2-9E19-481E9E760BBB

P2860

Q37151436-02BC84F1-8907-49DA-BCB1-3ECF02F997BE

Q37151436-03FEDCAF-26F4-4F22-923F-F3B320728E9A

Q37151436-0D1B2656-8813-4607-B6EA-B524DFD6B7E7

Q37151436-1478E9F9-9A39-4454-82B4-81C1D3DAFC7A

Q37151436-17395350-DC34-4E39-8BE3-94D360488403

Q37151436-1A6ED529-0FDE-4BE5-A123-060107E6F3D5

Q37151436-1EA57978-CF21-40E4-9BB6-A81D0DDD3478

Q37151436-2AEBAFFA-100C-44EF-8797-6B6C7ACA4203

Q37151436-2B68C262-2E39-4E2C-B97D-E37E64B0A544

Q37151436-2DD66DB1-ADC0-4409-A4D8-8A59E37C1519

P304

Q37151436-4A44A6B2-5614-4A8F-8CE8-9B40C54F8017

P31

Q37151436-A09E0A9B-B201-47B5-A0F4-AEA944A3D260

P356

Q37151436-2668F44B-0750-4458-968B-5EBFB32F39D9

P407

Q37151436-B72732C9-03C8-46DE-98FF-05C0C18D6650

P478

Q37151436-D04151BC-6EB1-4A33-B913-CF65A3B1A4D0

P577

Q37151436-A029F794-70A6-4B30-ADB5-5591D3F0E98C

P5875

Q37151436-03E35A7F-FC32-4830-912C-DE87185EC2B7

P698

Q37151436-B3D32FFA-5011-4C47-9C45-496049E80A4D

P921

Q37151436-40857200-A306-4552-A9FB-9CFC9321A7BE

Q37151436-8707FC00-39FA-493E-9A76-9B3280BD129E

Q37151436-DAA20EBC-A9A1-484A-8E82-7E173A0ACB23

P932

Q37151436-D0159E4F-3499-4362-9EA9-B871DC28689C

P356

J.BRAINRES.2008.08.089

P1433

P1476

Measures of striatal insulin r ...... e model of Parkinson's disease

@en

P2093

A A Gupte

http://www.w3.org/2001/XMLSchema#string

G L Bomhoff

http://www.w3.org/2001/XMLSchema#string

H Zhang

http://www.w3.org/2001/XMLSchema#string

J A Stanford

http://www.w3.org/2001/XMLSchema#string

J K Morris

http://www.w3.org/2001/XMLSchema#string

P C Geiger

http://www.w3.org/2001/XMLSchema#string

P2860

Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes

Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF-kappa B activation

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

Tyr624 and Tyr628 in insulin receptor substrate-2 mediate its association with the insulin receptor

The IRS-signalling system: a network of docking proteins that mediate insulin action

A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphory

Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation.

Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts

Mitochondria, oxidative damage, and inflammation in Parkinson's disease.

P304

185-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BRAINRES.2008.08.089

http://www.w3.org/2001/XMLSchema#string

P407

P478

1240

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23271112

http://www.w3.org/2001/XMLSchema#string

P698

18805403

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

corpus striatum

P932

2666001

http://www.w3.org/2001/XMLSchema#string